Cargando…
Preliminary Evaluation of Clinician Rated Outcome Measures in Mitochondrial Disease
Background: Currently there are no known cures and few effective treatments for mitochondrial disorders. It is also true there is a lack of knowledge about suitable clinician rated outcomes and how these change over time in this patient cohort. Objective: We sought to evaluate the validity and respo...
Autores principales: | Newman, Jane, Galna, Brook, Jakovljevic, Djordje G., Bates, Matthew G., Schaefer, Andrew M., McFarland, Robert, Turnbull, Douglass M., Trenell, Michael I., Taylor, Robert W., Rochester, Lynn, Gorman, Gráinne S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5271457/ https://www.ncbi.nlm.nih.gov/pubmed/27858729 http://dx.doi.org/10.3233/JND-140061 |
Ejemplares similares
-
Discrete gait characteristics are associated with m.3243A>G and m.8344A>G variants of mitochondrial disease and its pathological consequences
por: Galna, Brook, et al.
Publicado: (2013) -
Perceived fatigue is highly prevalent and debilitating in patients with mitochondrial disease
por: Gorman, Gráinne S., et al.
Publicado: (2015) -
Defining cardiac adaptations and safety of endurance training in patients with m.3243A>G-related mitochondrial disease()()()
por: Bates, Matthew G.D., et al.
Publicado: (2013) -
Concentric hypertrophic remodelling and subendocardial dysfunction in mitochondrial DNA point mutation carriers(†)
por: Bates, Matthew G.D., et al.
Publicado: (2013) -
Cardiomyopathy is common in patients with the mitochondrial DNA m.3243A>G mutation and correlates with mutation load
por: Hollingsworth, Kieren G., et al.
Publicado: (2012)